PMID: 12786804Jun 6, 2003Paper

Reduction of cell cycle progression in human erythroid progenitor cells treated with tumour necrosis factor alpha occurs with reduced CDK6 and is partially reversed by CDK6 transduction

British Journal of Haematology
Chunhua DaiS B Krantz

Abstract

Tumor necrosis factor alpha (TNFalpha) potently inhibits the in vitro growth of highly purified human d-6 erythroid colony forming cells (ECFC). Unlike the inhibitory effect of TNFalpha on other cells, including more immature ECFC, this antiproliferative effect of TNFalpha is not related to apoptosis because the d-6 cell descendants were morphologically normal, without apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labelling assay and without caspase activation by Western blots after TNFalpha treatment. TNFalpha did not appear to affect the cell cycle distribution, but the cell cycle duration was significantly longer in TNFalpha-treated cells. DNA synthesis was also significantly reduced by TNFalpha. Studies of various proteins that regulate the cell cycle showed that cyclin-dependent kinase 6 (CDK6) protein and mRNA levels were concomitantly decreased in the presence of TNFalpha, suggesting that inhibition of cell growth was related to reduced CDK6. To evaluate this, the CDK6 gene was transferred into ECFC using green fluorescence protein-retrovirus-mediated gene transfer. The results showed that the level of cell growth produced by TNFalpha was increased by 30% when the cells were transfected...Continue Reading

References

Aug 1, 1990·The Journal of Clinical Investigation·R T MeansS B Krantz
Nov 1, 1986·Cytometry·M VanderlaanL Stanker
Nov 1, 1980·Cell and Tissue Kinetics·N A Wright, D R Appleton
Dec 24, 1993·Science·S van den Heuvel, E Harlow
Feb 1, 1993·The Journal of Clinical Investigation·R T Means, S B Krantz
Jan 13, 1998·Current Opinion in Cell Biology·M D Planas-Silva, R A Weinberg
Oct 31, 1998·Oncogene·C Sidoti-de FraisseJ L Vayssière
Dec 8, 1998·European Journal of Immunology·P F PiguetC Barazzone
May 26, 1999·Current Biology : CB·J TschoppK Hofmann
Jun 8, 1999·Annual Review of Immunology·D WallachM P Boldin
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Jul 8, 1999·Journal of Medicinal Chemistry·R C Newton, C P Decicco
Jan 14, 2000·Journal of Clinical Immunology·P C Rath, B B Aggarwal
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A S Lundberg, R A Weinberg
Aug 1, 2000·The Journal of Biological Chemistry·K L FergusonR S Slack
Sep 19, 2000·American Journal of Obstetrics and Gynecology·L E ShieldsR G Andrews
Feb 24, 2001·Stem Cells·E D Israels, L G Israels
Feb 28, 2002·The Journal of Biological Chemistry·Xiaotang HuKenneth S Zuckerman

❮ Previous
Next ❯

Citations

Jul 25, 2008·Blood·Joel Anne Chasis, Narla Mohandas
Dec 11, 2013·Metabolic Syndrome and Related Disorders·Arun P PalanisamyKenneth D Chavin
Sep 18, 2015·Immunologic Research·Jimmy HomLionel Blanc
Jun 9, 2009·Biochemical and Biophysical Research Communications·Zhengmin YangXiaolong Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis